Key result
Triple-site biventricular pacing shows no resynchronization benefit over dual-site pacing despite improving LVEF.
Why the study?
Conventional biventricular stimulation with a single RV and LV lead is associated with persistent cardiac dyssynchrony in up to 30% of patients, motivating comparison with triple-site stimulation.
Does triple-site ventricular stimulation improve quality of ventricular resynchronization compared to conventional dual-site biventricular stimulation in patients with heart failure and atrial fibrillation?
RCT (n=40)
Single-blind
Crossover
Yes
Does triple-site ventricular stimulation improve quality of ventricular resynchronization compared to conventional dual-site biventricular stimulation in patients with heart failure and atrial fibrillation?
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The results of this study are of great interest, and the investigators should be congratulated for having tested this important pathophysiological concept. However, there are a few more considerations and some caveats that should be considered before widely applying triple-site stimulation in larger groups of patients.”
Triple-site ventricular stimulation with two left ventricular leads significantly improved left ventricular reverse remodeling compared to conventional CRT, although it did not improve the primary surrogate endpoint of resynchronization or functional status.
OBJECTIVES: We compared the effects of triple-site versus dual-site biventricular stimulation in candidates for cardiac resynchronization therapy. BACKGROUND: Conventional biventricular stimulation with a single right ventricular (RV) and a single left ventricular (LV) lead is associated with persistence of cardiac dyssynchrony in up to 30% of patients. METHODS: This multicenter, single-blind, crossover study enrolled 40 patients (mean age 70 +/- 9 years) with moderate-to-severe heart failure despite optimal drug treatment, a mean LV ejection fraction of 26 +/- 11%, and permanent atrial fibrillation requiring cardiac pacing for slow ventricular rate. A cardiac resynchronization therapy device connected to 1 RV and 2 LV leads, inserted in 2 separate coronary sinus tributaries, was successfully implanted in 34 patients. After 3 months of biventricular stimulation, the patients were randomly assigned to stimulation for 3 months with either 1 RV and 2 LV leads (3-V) or to conventional stimulation with 1 RV and 1 LV lead (2-V), then crossed over for 3 months to the alternate configuration. The primary study end point was quality of ventricular resynchronization (Z ratio). Secondary end points included reverse LV remodeling, quality of life, distance covered during 6-min hall walk, and procedure-related morbidity and mortality. Data from the 6- and 9-month visits were combined to compare end points associated with 2-V versus 3-V. RESULTS: Data eligible for protocol-defined analyses were available in 26 patients. No significant difference in Z ratio, quality of life, and 6-min hall walk was observed between 2-V and 3-V. However, a significantly higher LV ejection fraction (27 +/- 11% vs. 35 +/- 11%; p = 0.001) and smaller LV end-systolic volume (157 +/- 69 cm(3) vs. 134 +/- 75 cm(3); p = 0.02) and diameter (57 +/- 12 mm vs. 54 +/- 10 mm; p = 0.02) were observed with 3-V than with 2-V. There was a single minor procedure-related complication. CONCLUSIONS: Cardiac resynchronization therapy with 1 RV and 2 LV leads was safe and associated with significantly more LV reverse remodeling than conventional biventricular stimulation.
No takes yet. Share an insight, caveat, or question.
Leclercq et al. (2008) conducted an RCT in Congestive Heart Failure (n=40). Triple-site biventricular stimulation (1 RV and 2 LV leads) vs. Conventional dual-site biventricular stimulation (1 RV and 1 LV lead) was evaluated on Quality of ventricular resynchronization (Z ratio). Triple-site biventricular stimulation showed no significant difference in Z ratio compared to dual-site stimulation, but significantly increased left ventricular ejection fraction (35% vs 27%; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: